Evidence map›Paper›PMID 27887769›Full record

Trial reportAmerican journal of preventive medicine2017

Activity and Sedentary Time 10 Years After a Successful Lifestyle Intervention: The Diabetes Prevention Program.

Bonny Rockette-Wagner, Kristi L Storti, Dana Dabelea, Sharon Edelstein, Hermes Florez, Paul W Franks, Maria G Montez, Jeremy Pomeroy, Andrea M Kriska, Diabetes Prevention Program Research Group

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Long-Term Weight Loss Strategies for Obesity.The Journal of clinical endocrinology and metabolism · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Bonny Rockette-WagnerDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: bjr26@pitt.edu.
Kristi L StortiDepartment of Kinesiology, Health, and Sport Science, Indiana University of Pennsylvania, Indiana, Pennsylvania.
Dana DabeleaDepartment of Epidemiology, University of Colorado, Denver, Colorado.
Sharon EdelsteinGeorge Washington University Biostatistics Center, Rockville, Maryland.
Hermes FlorezDepartment of Medicine, University of Miami, Miami, Florida.
Paul W FranksDepartment of Clinical Science, Genetic and Molecular Epidemiology Unit, Lund University, Malmö, Sweden; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Maria G MontezUniversity of Texas Health Science Center, San Antonio, Texas.
Jeremy PomeroyDiabetes Epidemiology and Clinical Research Section, U.S. NIH, Phoenix, Arizona; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Marshfield, Wisconsin.
Andrea M KriskaDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Diabetes Prevention Program Research Group
University of Pittsburgh · USGeorge Washington University · USIndiana University of Pennsylvania · USLund University · SEMarshfield Clinic · USThe University of Texas Health Science Center at San Antonio · USUniversity of Colorado Denver · USUniversity of Miami · US

Funding

PRIMARY PREVENTION TRIAL--DATA COORDINATING CENTERU01DK048489 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JABLONSKI, KATHLEEN ANN, TEMPROSA, MARINELLA · 1994 to 2021
$84.8M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Julie Mathieu · 1986 to 2026
$41.4M
Post-DDP Follow-up StudyU01DK048413 · NIDDK · UNIVERSITY OF WASHINGTON · PI KAHN, STEVEN EMANUEL · 1994 to 2021
$13.7M
PRIMARY PREVENTION TRIAL (DPT-2)U01DK048397 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI NATHAN, DAVID M · 1994 to 2021
$12.0M
NIDDM PRIMARY PREVENTION TRIAL (DPT 2)U01DK048404 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI LAFERRERE, BLANDINE B · 1994 to 2021
$11.6M
PRIMARY PREVENTION TRIAL (DPT-2)U01DK048339 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ARANETA, MARIA ROSARIO GORREZ, MUDALIAR, SUNDER · 1994 to 2022
$11.4M
NIDDM PRIMARY PREVENTION TRIALU01DK048412 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VENDITTI, ELIZABETH MARY · 1994 to 2021
$11.4M
PRIMARY PREVENTION TRIALU01DK048443 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WATSON, KAROL E · 1994 to 2021
$10.2M
Post-DPP Follow-up StudyU01DK048375 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI DABELEA, DANA · 1994 to 2022
$10.0M
PRIMARY PREVENTION TRIAL (DPT-2)U01DK048380 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WALLIA, AMISHA · 1994 to 2021
$9.2M
POST-DPP FOLLOW-UP STUDYU01DK048514 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HAZUDA, HELEN P. · 1994 to 2021
$9.1M
Post-DPP Follow-Up StudyU01DK048437 · NIDDK · JOSLIN DIABETES CENTER · PI MUNSHI, MEDHA N · 1994 to 2021
$9.0M
NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R01 DK081345NIDDK NIH HHS U01 DK048339NIDDK NIH HHS U01 DK048375NIDDK NIH HHS U01 DK048380NIDDK NIH HHS U01 DK048397NIDDK NIH HHS U01 DK048400NIDDK NIH HHS U01 DK048404NIDDK NIH HHS U01 DK048407NIDDK NIH HHS U01 DK048412NIDDK NIH HHS U01 DK048413NIDDK NIH HHS U01 DK048437NIDDK NIH HHS U01 DK048443NIDDK NIH HHS U01 DK048485NIDDK NIH HHS U01 DK048489NIDDK NIH HHS U01 DK048514
6 · The paper itself

Abstract

introductionThis study aims to determine if evidence exists for a lasting effect of the Diabetes Prevention Program (DPP) lifestyle intervention on activity levels by comparing objectively collected activity data between the DPP Outcome Study (DPPOS) cohort and adults from the National Health and Nutrition Examination Survey (NHANES; 2003-2006).

methodsAverage minutes/day of light and moderate to vigorous physical activity (MVPA) and sedentary behavior from ActiGraph accelerometers (collected 2010-2012) were examined (2013-2014) for comparable DPPOS and NHANES subgroups by age, sex, and diabetes status. Longitudinal questionnaire data on leisure activity, collected yearly from DPP baseline to the time of accelerometer measurement (1996-2010; 11.9-year mean follow-up), were also examined to provide support for a long-term intervention effect.

resultsAverage minutes/day of accelerometer-derived MVPA was higher in all DPPOS subgroups versus NHANES subgroups of similar age/sex/diabetes status; with values as much as twice as high in some DPPOS subgroups. Longitudinal questionnaire data from DPP/DPPOS showed a maintained increase of 1.24 MET hours/week (p=0.026) of leisure activity in DPPOS participants from all original study arms between DPP baseline and accelerometer recording. There were no consistent differences between comparable DPPOS and NHANES subgroups for accelerometer-derived sedentary or light-intensity activity minutes/day.

conclusionsMore than 10 years after the start of DPP, DPPOS participants performed more accelerometer-measured MVPA than similar adults from NHANES. Longitudinal questionnaire data support the accelerometer-based findings by suggesting that leisure activity levels at the time of accelerometer recording remained higher than DPP baseline levels.

Indexed as

Leisure ActivitiesLife StyleAccelerometryAdultAgedCohort StudiesDiabetes Mellitus, Type 2ExerciseFemaleHealth BehaviorHumansLongitudinal StudiesMaleMiddle AgedNutrition SurveysSedentary Behavior

Identifiers

PMID27887769
PMCPMC5318249
OpenAlexW2549897028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.